Matching Items (5)
Filtering by

Clear all filters

136004-Thumbnail Image.png
Description
This is a study of the adaptive behaviors of individuals with Autism Spectrum Disorder using the Vineland II Adaptive Behavioral Scale (VABS-II). This scale was used to determine the overall functioning level of individuals with Autism Spectrum Disorder at the beginning, and will be used at the end, of a

This is a study of the adaptive behaviors of individuals with Autism Spectrum Disorder using the Vineland II Adaptive Behavioral Scale (VABS-II). This scale was used to determine the overall functioning level of individuals with Autism Spectrum Disorder at the beginning, and will be used at the end, of a year-long study beginning at Arizona State University. This larger study is determining what the effects are, if any, of a combination of nutritional and dietary treatments in individuals with Autism Spectrum Disorder. However, this paper only examines the VABS-II results of forty-three participants in the study, as well as their hand-grip strength. It was found that individuals with Autism Spectrum Disorder are substantially delayed in all four domains (communication, daily living skills, social skills, and motor skills) of adaptive behaviors measured by the VABS-II, particularly in communication. This study will be completed in May 2013, when it will be determined what the effects of these treatments are, if any.
ContributorsAdams, Rebecca (Author) / Ingram-Waters, Mary (Thesis director) / Krajmalnik-Brown, Rosa (Committee member) / Pollard, Elena (Committee member) / Barrett, The Honors College (Contributor)
Created2012-05
133696-Thumbnail Image.png
Description
The gastrointestinal (GI) tract is home to a complex and diverse microbial ecosystem that contributes to health or disease in many aspects. While bacterial species are the majority in the GI tract, their cohabitants, fungal species, should not be forgotten. Children with autism spectrum disorder (ASD) often suffer from GI

The gastrointestinal (GI) tract is home to a complex and diverse microbial ecosystem that contributes to health or disease in many aspects. While bacterial species are the majority in the GI tract, their cohabitants, fungal species, should not be forgotten. Children with autism spectrum disorder (ASD) often suffer from GI disorders and associated symptoms, implying a role the bacterial and fungal gut microbiota play in maintaining human health. The irregularities in GI symptoms can negatively affect the overall quality of life or even worsen behavioral symptoms the children present. Even with the increase in the availability of next-generation sequencing technologies, the composition and diversities of fungal microbiotas are understudied, especially in the context of ASD. We therefore aimed to investigate the gut mycobiota of 36 neurotypical children and 38 children with ASD. We obtained stool samples from all participants, as well as autism severity and GI symptom scores to help us understand the effect the mycobiome has on these symptoms. By targeting the fungal internal transcribed spacer (ITS) and bacterial 16S rRNA V4 regions, we obtained fungal and bacterial amplicon sequences, from which we investigated the diversities, composition, and potential link between two different ecological clades. From fungal amplicon sequencing results, we observed a significant decrease in the observed fungal OTUs in children with ASD, implying a lack of potentially beneficial fungi in ASD subjects. We performed Bray-Curtis principal coordinates analysis and observed significant differences in fungal microbiota composition between the two groups. Taxonomic analysis showed higher relative abundances of Candida , Pichia, Penicillium , and Exophiala in ASD subjects, yet due to a large dispersion of data, the differences were not statistically significant. Interestingly, we observed a bimodal distribution of Candida abundances within children with ASD. Candida's relative abundance was not significantly correlated with GI scores, but children with high Candida relative abundances presented significantly higher Autism Treatment Evaluation Checklist (ATEC) scores, suggesting a role of Candida on ASD behavioral symptoms. Regarding the bacterial gut microbiota, we found marginally lower observed OTUs and significantly lower relative abundance of Prevotella in the ASD group, which was consistent with previous studies. Taken together, we demonstrated that autism is closely linked with a distinct gut mycobiota, characterized by a loss of fungal and bacterial diversity and an altered fungal and bacterial composition.
ContributorsPatel, Jigar (Author) / Krajmalnik-Brown, Rosa (Thesis director) / Kang, Dae Wook (Committee member) / Adams, James (Committee member) / School of Molecular Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2018-05
134934-Thumbnail Image.png
Description
The purpose of this study, originally, was to contribute to the completion of a meta-analysis conducted by Mara Wierstra from the University of Virginia. Wierstra had requested individual participant data from two separate studies conducted in our lab: "Acute bouts of assisted cycling improves cognitive and upper extremity movement functions

The purpose of this study, originally, was to contribute to the completion of a meta-analysis conducted by Mara Wierstra from the University of Virginia. Wierstra had requested individual participant data from two separate studies conducted in our lab: "Acute bouts of assisted cycling improves cognitive and upper extremity movement functions in adolescents with Down syndrome" and "Assisted Cycling Therapy (ACT) improves inhibition in adolescents with autism spectrum disorder." From the data requested, the participants were required to complete three separate tests (i.e., Tower of London, Trail Making Task and the Stroop Test). After compiling the data and sending it to her, we decided to conduct a small meta-analysis of our own, drawing connecting conclusions from the data from the two studies. We concluded that observationally our data suggest an advantage for ACT over voluntary cycling and no cycling across two separate populations (i.e., Autism Spectrum Disorder and Down syndrome), and across different measures of executive function (i.e., Stroop Test, Trail Making Test, and Tower of London). The data suggest that the ACT interventions may promote the upregulation of neurotropic factors leading to neurogenesis in the prefrontal cortex of the brain.
ContributorsParker, Cade Joseph (Author) / Ringenbach, Shannon (Thesis director) / Holzapfel, Simon (Committee member) / School of Nutrition and Health Promotion (Contributor) / Barrett, The Honors College (Contributor)
Created2016-12
165705-Thumbnail Image.png
Description
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that not only affects communication and behavior with often co-occurring gastrointestinal (GI) issues such as constipation and diarrhea. Recent studies have shown that many GI and behavioral symptoms in individuals with ASD are linked to dysregulated immune systems and altered gut microbiomes

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that not only affects communication and behavior with often co-occurring gastrointestinal (GI) issues such as constipation and diarrhea. Recent studies have shown that many GI and behavioral symptoms in individuals with ASD are linked to dysregulated immune systems and altered gut microbiomes (bacteria and fungi). In fungal microbiota, a common GI commensal and opportunistic pathogen, Candida, has been found in higher abundance in children with ASD. Few studies have investigated total IgA and IgG levels in both blood and feces of ASD individuals with relatively mixed findings, showing either significantly higher or lower IgG and IgA abundance in ASD vs. TD (typically developing) individuals. Mixed results are likely due to a lack of a standardized method of immunoglobulin (Ig) quantification. In this study, we attempt to standardize an enzyme-linked immunoassay (ELISA) procedure to measure total IgA, total IgG, and anti-Candida albicans IgA and IgG levels in fecal samples of adults with ASD. Measuring Ig levels can reflect altered gut microbiota, GI tract, and immune status in ASD and potentially characterize Ig as a biomarker for ASD. Although we were unable to successfully standardize an Ig ELISA quantification method, SDS-PAGE confirmed the presence of IgA in fecal Ig extracts. Based on our ELISA results, we suspect that dilution factors of fecal Ig extracts need to be modified further to detect the IgA within the detection range. The experimental methodology in this study can be used as a reference to develop and improve a full-proof method of quantifying immunoglobulin from ASD fecal samples, which will help to reveal immune status in ASD.
ContributorsMarwah, Mira (Author) / Campos, Nicole (Co-author) / Krajmalnik-Brown, Rosa (Thesis director) / Nirmalkar, Khemlal (Committee member) / Barrett, The Honors College (Contributor) / School of Life Sciences (Contributor) / Department of Psychology (Contributor)
Created2022-05
165760-Thumbnail Image.png
Description
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that not only affects communication and behavior with often co-occurring gastrointestinal (GI) issues such as constipation and diarrhea. Recent studies have shown that many GI and behavioral symptoms in individuals with ASD are linked to dysregulated immune systems and altered gut microbiomes

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that not only affects communication and behavior with often co-occurring gastrointestinal (GI) issues such as constipation and diarrhea. Recent studies have shown that many GI and behavioral symptoms in individuals with ASD are linked to dysregulated immune systems and altered gut microbiomes (bacteria and fungi). In fungal microbiota, a common GI commensal and opportunistic pathogen, Candida, has been found in higher abundance in children with ASD. Few studies have investigated total IgA and IgG levels in both blood and feces of ASD individuals with relatively mixed findings, showing either significantly higher or lower IgG and IgA abundance in ASD vs. TD (typically developing) individuals. Mixed results are likely due to a lack of a standardized method of immunoglobulin (Ig) quantification. In this study, we attempt to standardize an enzyme-linked immunoassay (ELISA) procedure to measure total IgA, total IgG, and anti-Candida albicans IgA and IgG levels in fecal samples of adults with ASD. Measuring Ig levels can reflect altered gut microbiota, GI tract, and immune status in ASD and potentially characterize Ig as a biomarker for ASD. Although we were unable to successfully standardize an Ig ELISA quantification method, SDS-PAGE confirmed the presence of IgA in fecal Ig extracts. Based on our ELISA results, we suspect that dilution factors of fecal Ig extracts need to be modified further to detect the IgA within the detection range. The experimental methodology in this study can be used as a reference to develop and improve a full-proof method of quantifying immunoglobulin from ASD fecal samples, which will help to reveal immune status in ASD.
ContributorsCampos, Nicole (Author) / Marwah, Mira (Co-author) / Krajmalnik-Brown, Rosa (Thesis director) / Nirmalkar, Khemlal (Committee member) / Barrett, The Honors College (Contributor) / Sanford School of Social and Family Dynamics (Contributor) / School of Life Sciences (Contributor)
Created2022-05